372 related articles for article (PubMed ID: 19481695)
1. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Trapani A; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
[TBL] [Abstract][Full Text] [Related]
2. A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.
Maestrelli F; Garcia-Fuentes M; Mura P; Alonso MJ
Eur J Pharm Biopharm; 2006 Jun; 63(2):79-86. PubMed ID: 16527473
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
4. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
[TBL] [Abstract][Full Text] [Related]
5. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
Krauland AH; Alonso MJ
Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
[TBL] [Abstract][Full Text] [Related]
7. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
Kim DG; Jeong YI; Choi C; Roh SH; Kang SK; Jang MK; Nah JW
Int J Pharm; 2006 Aug; 319(1-2):130-8. PubMed ID: 16713152
[TBL] [Abstract][Full Text] [Related]
8. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
[TBL] [Abstract][Full Text] [Related]
10. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
12. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles.
Bodnar M; Hartmann JF; Borbely J
Biomacromolecules; 2006 Nov; 7(11):3030-6. PubMed ID: 17096528
[TBL] [Abstract][Full Text] [Related]
14. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability.
Zerrouk N; Corti G; Ancillotti S; Maestrelli F; Cirri M; Mura P
Eur J Pharm Biopharm; 2006 Apr; 62(3):241-6. PubMed ID: 16226882
[TBL] [Abstract][Full Text] [Related]
15. Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.
Beck-Broichsitter M; Thieme M; Nguyen J; Schmehl T; Gessler T; Seeger W; Agarwal S; Greiner A; Kissel T
Macromol Biosci; 2010 Dec; 10(12):1527-35. PubMed ID: 20824691
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
17. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
Parrot-Lopez H; Perret F; Bertino-Ghera B
Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
Wang S; Jiang T; Ma M; Hu Y; Zhang J
Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
[TBL] [Abstract][Full Text] [Related]
19. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
20. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
Zhang J; Chen XG; Peng WB; Liu CS
Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
